semaglutide twice a week US, Japan Patients With Diabetes Discontinue After First Year Messaged provider re: GLP-1 discontinuation

Ask your assigned provider what specific "significant difference" from the commercially available FDA-approved product will be documented in your prescription - this is the legal basis for a 503A compounded prescription under current FDA guidance, and a provider should answer clearly

This helps maintain physiologic hormone patterns rather than overwhelming the body with synthetic GH

2020;72:e108 Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al

Without add-back therapy, these medications can be associated with a decrease in bone density if taken longer than months

The FDA label does not require routine allergy testing before starting tirzepatide, but individual risk assessment should guide clinical decision-making